Literature DB >> 2165126

Abrogation of the requirement for feeder cell interaction and T cell receptor stimulation of lymphocytes infected with retroviral vectors.

C Laker1, G Gräning, A Kelso, C Stocking, W Ostertag.   

Abstract

Infection of sensitive adult mice with myeloproliferative sarcoma virus (MPSV) results in a myeloproliferative syndrome. Two components of the viral genome are required to induce this unique pathology: the mos oncogene and sequences within the U3 region of the long terminal repeat (LTR). In studies designed to identify the target cell of MPSV and thus better understand the mechanism by which a myeloproliferative syndrome is induced, we have infected a series of T cell lines with MPSV-based vectors. The results presented here show that infection with neoR MPSV abrogates the requirement for an antigen-specific or feeder cell-dependent stimulation, without altering the requirement for interleukin 2. Significantly, this response is not dependent on the mos oncogene, but requires sequences within the U3 region of the MPSV LTR. No alteration in the constitutive or induced levels of lymphokines released by these cells was observed. These results suggest a model in which T cells acquire a proliferative advantage by uncoupling the proliferative response from the lymphokine synthesis that is induced by activation of the T cell receptor. These cells are thus poised for antigen stimulation and secretion of cytokines that stimulate myelopoiesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165126      PMCID: PMC2188329          DOI: 10.1084/jem.172.2.447

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

1.  Mouse myelomas and lymphomas in culture.

Authors:  K Horibata; A W Harris
Journal:  Exp Cell Res       Date:  1970-04       Impact factor: 3.905

2.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

3.  Myeloproliferative virus, a cloned murine sarcoma virus with spleen focus-forming properties in adult mice.

Authors:  W Ostertag; K Vehmeyer; B Fagg; I B Pragnell; W Paetz; M C Le Bousse; F Smadja-Joffe; B Klein; C Jasmin; H Eisen
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

4.  Independent regulation of granulocyte-macrophage colony-stimulating factor and multi-lineage colony-stimulating factor production in T lymphocyte clones.

Authors:  A Kelso; D Metcalf; N M Gough
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

5.  Thymoma production of T cell growth factor (Interleukin 2).

Authors:  J J Farrar; J Fuller-Farrar; P L Simon; M L Hilfiker; B M Stadler; W L Farrar
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

6.  Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes.

Authors:  U R Rapp; J L Cleveland; K Brightman; A Scott; J N Ihle
Journal:  Nature       Date:  1985 Oct 3-9       Impact factor: 49.962

7.  Inheritance of susceptibility to the myeloproliferative sarcoma virus: effect of the Fv-2 locus and evidence for a myeloproliferative sarcoma virus resistance locus.

Authors:  W Ostertag; T Odaka; F Smadja-Joffe; C Jasmin
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

8.  Effects of myeloproliferative sarcoma virus on the pluripotential stem cell and granulocyte precursor cell populations of DBA/2 mice.

Authors:  B Klein; C Le Bousse; B Fagg; F Smajda-Joffe; K Vehmeyer; K J Mori; C Jasmin; W Ostertag
Journal:  J Natl Cancer Inst       Date:  1981-05       Impact factor: 13.506

9.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06

10.  Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor.

Authors:  J E Gootenberg; F W Ruscetti; J W Mier; A Gazdar; R C Gallo
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.